Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase II Randomized, Double-Blind, Multi-Center Study of Avastin Plus Docetaxel or Tarceva versus Docetaxel or Tarceva Alone in Patients with Recurrent or Refractory Non-Small Cell Lung Carcinoma
erlotinib
OSI2950G
NCT00095225
malignant neoplasm of bronchus and lung
Phase 2
 
January 2016

Powered by ideaPoint, Inc.